Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 721 AL 735

Cerebrospinal fluid biomarkers in Parkinson disease

Parnetti L, Castrioto A, Chiasserini D, Persichetti E, Tambasco N, El-Agnaf O, Calabresi P.

Nat Rev Neurol. 2013 Mar;9(3):131-40. doi: 10.1038/nrneurol.2013.10. Epub 2013 Feb 19.

New findings concerning vertebrate porin II--on the relevance of glycine motifs of type-1 VDAC

Thinnes FP.

Mol Genet Metab. 2013 Apr;108(4):212-24. doi: 10.1016/j.ymgme.2013.01.008. Epub 2013 Jan 26.

Progressive resistance exercise improves strength and physical performance in people with mild to moderate Parkinson's disease: a systematic review

Lima LO, Scianni A, Rodrigues-de-Paula F.

J Physiother. 2013 Mar;59(1):7-13. doi: 10.1016/S1836-9553(13)70141-3.

Musculoskeletal problems in Parkinson's disease

Kim YE, Jeon BS.

J Neural Transm (Vienna). 2013 Apr;120(4):537-42. doi: 10.1007/s00702-012-0960-2. Epub 2013 Feb 19.

Impact of antipsychotics and anticholinergics on autonomic modulation in patients with schizophrenia

Huang WL, Chang LR, Kuo TB, Lin YH, Chen YZ, Yang CC.

J Clin Psychopharmacol. 2013 Apr;33(2):170-7. doi: 10.1097/JCP.0b013e3182839052.

From aberrant salience to jumping to conclusions: dopaminergic pathways to delusions in Parkinson disease

Poletti M, Bonuccelli U.

J Clin Psychopharmacol. 2013 Apr;33(2):149-51. doi: 10.1097/JCP.0b013e3182854989.

Community-based group exercise for persons with Parkinson disease: a randomized controlled trial

Combs SA, Diehl MD, Chrzastowski C, Didrick N, McCoin B, Mox N, Staples WH, Wayman J.

NeuroRehabilitation. 2013;32(1):117-24. doi: 10.3233/NRE-130828.

The effect of gym training on multiple outcomes in Parkinson's disease: a pilot randomised waiting-list controlled trial

Poliakoff E, Galpin AJ, McDonald K, Kellett M, Dick JP, Hayes S, Wearden AJ.

NeuroRehabilitation. 2013;32(1):125-34. doi: 10.3233/NRE-130829.

Effectiveness of electroconvulsive therapy for drug-induced parkinsonism in the elderly

Sadananda SK, Holla B, Viswanath B, Narasimha A, Sebastian A, Math SB, Chandrashekar CR.

J ECT. 2013 Mar;29(1):e6-7. doi: 10.1097/YCT.0b013e3182611563.

Validity and metric of MiniMental Parkinson and MiniMental State Examination in Parkinson's disease

Isella V, Mapelli C, Morielli N, De Gaspari D, Siri C, Pezzoli G, Antonini A, Poletti M, Bonuccelli U, Picchi L, Napolitano A, Vista M, Greco A, Appollonio IM.

Neurol Sci. 2013 Oct;34(10):1751-8. doi: 10.1007/s10072-013-1328-6. Epub 2013 Feb 20.

Rhythm-specific modulation of the sensorimotor network in drug-naive patients with Parkinson's disease by levodopa

Esposito F, Tessitore A, Giordano A, De Micco R, Paccone A, Conforti R, Pignataro G, Annunziato L, Tedeschi G.

Brain. 2013 Mar;136(Pt 3):710-25. doi: 10.1093/brain/awt007. Epub 2013 Feb 18.

Diffusion-weighted imaging and its relationship to microglial activation in parkinsonian syndromes

Kobylecki C, Counsell SJ, Cabanel N, Wächter T, Turkheimer FE, Eggert K, Oertel W, Brooks DJ, Gerhard A.

Parkinsonism Relat Disord. 2013 May;19(5):527-32. doi: 10.1016/j.parkreldis.2013.01.017. Epub 2013 Feb 18.

Nonpharmacological enhancement of cognitive function in Parkinson's disease: a systematic review

Hindle JV, Petrelli A, Clare L, Kalbe E.

Mov Disord. 2013 Jul;28(8):1034-49. doi: 10.1002/mds.25377. Epub 2013 Feb 20.

Glycine site agonists of the N-methyl-D-aspartate receptor and Parkinson's disease: a hypothesis

Heresco-Levy U, Shoham S, Javitt DC.

Mov Disord. 2013 Apr;28(4):419-24. doi: 10.1002/mds.25306. Epub 2013 Feb 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias